Drug Topics
CONTINUE TO SITE >

OR WAIT 15 SECS

Drug Topics
Spotlight
Clinical
News
Media
Practice Type
Conferences
Publications
Subscribe

  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences and Drug Topics. All rights reserved.

Spotlight
  • Cardiovascular Clinical Consult
  • Diabetes
  • Generics
  • Gut Health
  • Heart Health
  • Immunization
  • Migraine
  • Oncology
  • Respiratory
  • Shingles
  • Technology
  • ThoughtSpot 2020
ClinicalSee All >
  • Anticoagulants
  • Autoimmune Diseases
  • Biosimilars
  • CBD
  • COPD Management
  • Coronavirus
  • Dermatology
  • Diabetes
  • Generics
  • Gut Health
  • Heart Health
  • Immunization
  • Influenza
  • Oncology
  • Pain Management
  • Pediatrics
  • Respiratory
  • Shingles
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.

There will be fewer Part D plans to wade through next year

April 10, 2006

Conceding that there are too many Part D prescription drug plans for Medicare beneficiaries to choose from now, HHS is limiting the number of PDPs insurers can offer from three per region this year to two next year. Insurers that offer enhanced coverage may have more leeway to offer three plans.

There will be fewer Part D plans to wade through next year

Conceding that there are too many Part D prescription drug plans for Medicare beneficiaries to choose from now, HHS is limiting the number of PDPs insurers can offer from three per region this year to two next year. Insurers that offer enhanced coverage may have more leeway to offer three plans. The results of a Drug Topics on-line poll support this shift. More than eight out of 10 people who responded to an Instant Poll posted on DT's Web site in March believe the government should reduce the number of Medicare Part D drug plans each insurer offers next year. Insurers should be limited to just two plans-one basic, one enhanced-in each region, they agreed. Only 18% of respondents disagreed with this proposition; they believe seniors should have more choices available, while 1% said they didn't know whether drug plans should be increased or decreased. A total of 494 pharmacists and others voted in this poll.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

Related Content:

News